Wednesday 5 December 2001
Fellowships of The Institute of Cancer Research were conferred on two distinguished cancer research scientists, Professor Tom Connors and Dr Michael Crumpton, at The Institute's Graduation Ceremony on 3rd December. Lord Faringdon, Chairman of The Institute's Trustees, presented the awards at the Senate House, University of London.
The Fellowship is conferred upon those exceptional individuals who have made outstanding contributions to cancer research, treatment or education.
Professor Tom Connors specialised in the action and early clinical development of anti-cancer agents. He was Head of the Department of Experimental Chemotherapy at the Chester Beatty Laboratories of The Institute of Cancer Research from 1960 until 1976, and subsequently became Director of the MRC Toxicology Unit. He has been an inspiration for generations of scientists and clinicians, and is widely acknowledged to be the father of cancer chemotherapy in both the UK and Europe. Currently he is an Honorary Professor at the School of Pharmacy, University of London.
Dr Michael Crumpton, a Fellow of the Royal Society, was a leading investigator in cell structure and cellular mechanisms during his career at the Imperial Cancer Research Fund, where he became Director of Laboratory Research until 1993. Dr Crumpton is a Trustee of Breakthrough Breast Cancer and Chairman of their Scientific Advisory Committee. He served for a number of years on the Council of the Institute. He is also a Non-Executive Director of Amersham BioSciences.
- ends -
For more information, please contact:
The Institute of Cancer Research
Tel: 0207 970 6030
email: [email protected]
Please note:
Unfortunately the press office are unable to answer queries from the general public. For general cancer information please refer to The Institute's cancer information page.